BIMATOPROST MYLAN PHARMA 0,1 mg/mL, collyre en solution
collyre en solution
ophtalmique
Autorisation active
Procédure nationale
Commercialisée
4/28/2017
MYLAN SAS
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!